New Pneumococcal Vaccine Study for Infants
Part of Infections clinical trials.
This study tests a new vaccine to protect infants from pneumococcal disease (a serious bacterial infection). Researchers want to see how well the vaccine works and how safe it is in healthy babies aged 2–6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your infant must be between 2 and 6 months old (or exactly 2 months for one group)
- Your infant must be in good health with no major birth defects or serious ongoing medical conditions
- Your infant has not received any pneumococcal vaccine before (licensed or experimental)
- Your infant has no history of severe allergic reactions or serious side effects from previous vaccines
- Your infant has no acute or chronic medical, psychiatric, or lab abnormalities that could interfere with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a catch-up pneumococcal vaccine for children and adolescents who may have missed some doses. It aims to see how safe and effective the vaccine is in healthy kids aged 15 months to 17 years.
This study tests whether a new pneumococcal vaccine (which protects against a serious bacterial infection) is safe in healthy 2-month-old infants. Researchers will watch for side effects and help protect future babies from pneumococcal disease.
This trial tests a new 23-valent pneumococcal vaccine to see if it safely protects healthy people against pneumonia and other infections caused by pneumococcal bacteria.
This study tests a new pneumococcal vaccine (PCV15) to see how well it protects against carrying the bacteria that can cause pneumonia. Healthy adults aged 18–50 who have not had a pneumococcal vaccine in the last 5 years may join.
This study tests an investigational vaccine that may protect infants against infections caused by a bacteria called Streptococcus pneumoniae, which can cause pneumonia and other serious illnesses. The vaccine is given to healthy babies around 2 months old, and the study will see how well it works and how safe it is.
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
Hear when a new Pneumococcal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.